The prevalence of SETBP1 mutations in CNL has been reported to be between 14% and ~56%19,76,121,126,131 and these mutations are enriched in CNL patients harboring CSF3R mutations121. This evidence concerns the gene CSF3R and chronic neutrophilic leukemia.